Table 4. CTC count by pStage.

	No. T0/Tis (%)*	No. T1-4 or N1/2 (%)*	No. Concordance/Total No. (%)	κ (95% CI)
Baseline:	5	11	12/16 (75)	0.48 (0.05—0.9)
Low	4 (57)	3 (43)
Medium/high	1 (11)	8 (89)
1-Mo followup:†	5	10	7/15 (46.7)	0.08 (−0.3–0.4)
Low	4 (36)	7 (64)
Medium/high	1 (25)	3 (75)
Baseline vs followup paired samples:	5	10	–	–
Low vs low	3 (50)	3 (50)
Low vs medium/high	1 (100)	0
Medium/high vs low	1 (20)	4 (80)
Medium/high vs medium/high	0	3 (100)

^*Subset of neoadjuvant group underwent cystectomy and had p stage available (T0/Tis—CTC low and T1-4 or N1/2—CTC medium/high).

^†After 1 chemotherapy cycle.